NAUT · Nautilus Biotechnology, Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-18 | McIlwain Matthew S |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to reporting person's continuous status as a "Service Provider" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, one-twelfth (1/12th) of the shares subject to the Option shall vest on a monthly basis following the date of grant on the same day of the month as such grant date (or on the last day of the month, if there is no corresponding day in such month). |
Stock Option (Right to Buy)
|
45,000 |
| 2026-06-18 | Akinsanya Karen |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to reporting person's continuous status as a "Service Provider" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, one-twelfth (1/12th) of the shares subject to the Option shall vest on a monthly basis following the date of grant on the same day of the month as such grant date (or on the last day of the month, if there is no corresponding day in such month). |
Stock Option (Right to Buy)
|
45,000 |
| 2026-06-18 | NAZEM FARZAD |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to reporting person's continuous status as a "Service Provider" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, one-twelfth (1/12th) of the shares subject to the Option shall vest on a monthly basis following the date of grant on the same day of the month as such grant date (or on the last day of the month, if there is no corresponding day in such month). |
Stock Option (Right to Buy)
|
45,000 |
| 2026-06-18 | Epperly Melissa B, |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to reporting person's continuous status as a "Service Provider" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, one-twelfth (1/12th) of the shares subject to the Option shall vest on a monthly basis following the date of grant on the same day of the month as such grant date (or on the last day of the month, if there is no corresponding day in such month). |
Stock Option (Right to Buy)
|
45,000 |
| 2026-06-18 | Posard Matthew L. |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to reporting person's continuous status as a "Service Provider" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, one-twelfth (1/12th) of the shares subject to the Option shall vest on a monthly basis following the date of grant on the same day of the month as such grant date (or on the last day of the month, if there is no corresponding day in such month). |
Stock Option (Right to Buy)
|
45,000 |
| 2026-06-02 | AH Equity Partners Bio II, L.L.C. |
10% Owner |
Sell↓
Filing footnotes — Common Stock (Indirect)
The reported securities are held by AH Bio Fund II, L.P. ("AH Bio Fund II"), for itself and as nominee for AH Bio Fund II-B, L.P. AH Equity Partners Bio II, L.L.C. ("AH EP Bio II") is the general partner of AH Bio Fund II and has sole voting and dispositive power with regard to the securities held by AH Bio Fund II for itself and as nominee. The managing members of AH EP Bio II are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to share voting and dispositive power with respect to the securities held by AH Bio Fund II for itself and as nominee. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by AH Bio Fund II for itself and as nominee (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any. |
Common Stock
(I)
|
4,615,974 |
| 2026-06-02 | AH Equity Partners Bio II, L.L.C. |
10% Owner |
Sell↓
Filing footnotes — Common Stock (Indirect)
The reported securities are held by Andreessen Horowitz LSV Fund II, L.P. ("AH LSV Fund II"), for itself and as nominee for Andreessen Horowitz LSV Fund II-B, L.P. and Andreessen Horowitz LSV Fund II-Q, L.P. AH Equity Partners LSV II, L.L.C. ("AH EP LSV II") is the general partner of AH LSV Fund II and has sole voting and dispositive power with regard to the securities held by AH LSV Fund II for itself and as nominee. The managing members of AH EP LSV II are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to share voting and dispositive power with respect to the securities held by AH LSV Fund II for itself and as nominee. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by AH LSV Fund II for itself and as nominee (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any. |
Common Stock
(I)
|
384,026 |
| 2026-03-04 | Patel Sujal M |
Director, CEO, President, and Secretary, 10% Owner |
Buy↑
Filing footnotes — Common Stock (Direct)
Represents the weighted average share price of an aggregate total of 25,000 shares purchased in the price range of $2.48 to $2.6095 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |
Common Stock
|
25,000 |
| 2026-03-02 | Mallick Parag |
Director, Chief Scientist, 10% Owner |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to reporting person's continuous status as a "Service Provider" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement Date is January 1, 2026. |
Stock Option (Right to Buy)
|
280,000 |
| 2026-03-02 | Patel Sujal M |
Director, CEO, President, and Secretary, 10% Owner |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to reporting person's continuous status as a "Service Provider" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement Date is January 1, 2026. |
Stock Option (Right to Buy)
|
650,000 |
| 2026-03-02 | Weld Gwen E |
Chief People Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to reporting person's continuous status as a "Service Provider" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement Date is January 1, 2026. |
Stock Option (Right to Buy)
|
160,000 |
| 2026-03-02 | Suzuki Kentaro |
Chief Marketing Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to reporting person's continuous status as a "Service Provider" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement Date is January 1, 2026. |
Stock Option (Right to Buy)
|
160,000 |
| 2026-03-02 | Mowry Anna |
CFO and Treasurer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to reporting person's continuous status as a "Service Provider" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement Date is January 1, 2026. |
Stock Option (Right to Buy)
|
160,000 |
| 2026-03-02 | Sankar Subramanian |
Senior VP, Product Development |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to reporting person's continuous status as a "Service Provider" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement Date is January 1, 2026. |
Stock Option (Right to Buy)
|
160,000 |
| 2026-03-02 | Murphy Matthew B. |
General Counsel |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to reporting person's continuous status as a "Service Provider" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement Date is January 1, 2026. |
Stock Option (Right to Buy)
|
160,000 |
| 2025-11-06 | Suzuki Kentaro |
Chief Marketing Officer |
Buy↑
|
Common Stock
|
4,000 |
| 2025-09-08 | Patel Sujal M |
Director, CEO, President, and Secretary, 10% Owner |
Buy↑
Filing footnotes — Common Stock (Direct)
Represents the weighted average share price of an aggregate total of 83,500 shares purchased in the price range of $0.6581 to $0.7145 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |
Common Stock
|
83,500 |
| 2025-09-05 | Patel Sujal M |
Director, CEO, President, and Secretary, 10% Owner |
Buy↑
Filing footnotes — Common Stock (Direct)
Represents the weighted average share price of an aggregate total of 116,500 shares purchased in the price range of $0.6547 to $0.6899 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |
Common Stock
|
116,500 |
| 2025-09-04 | Murphy Matthew B. |
General Counsel |
Buy↑
Filing footnotes — Common Stock (Indirect)
Shares held by the Murphy Family Trust. The reporting person is the Trustee of the Murphy Family Trust. |
Common Stock
(I)
|
20,000 |
| 2025-06-23 | Akinsanya Karen |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to reporting person's continuous status as a "Service Provider" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, one-twelfth (1/12th) of the shares subject to the Option shall vest on a monthly basis following the date of grant on the same day of the month as such grant date (or on the last day of the month, if there is no corresponding day in such month). |
Stock Option (Right to Buy)
|
45,000 |
| 2025-06-23 | Posard Matthew L. |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to reporting person's continuous status as a "Service Provider" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, one-twelfth (1/12th) of the shares subject to the Option shall vest on a monthly basis following the date of grant on the same day of the month as such grant date (or on the last day of the month, if there is no corresponding day in such month). |
Stock Option (Right to Buy)
|
45,000 |
| 2025-06-23 | McIlwain Matthew S |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to reporting person's continuous status as a "Service Provider" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, one-twelfth (1/12th) of the shares subject to the Option shall vest on a monthly basis following the date of grant on the same day of the month as such grant date (or on the last day of the month, if there is no corresponding day in such month). |
Stock Option (Right to Buy)
|
45,000 |
| 2025-06-23 | Epperly Melissa B, |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to reporting person's continuous status as a "Service Provider" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, one-twelfth (1/12th) of the shares subject to the Option shall vest on a monthly basis following the date of grant on the same day of the month as such grant date (or on the last day of the month, if there is no corresponding day in such month). |
Stock Option (Right to Buy)
|
45,000 |
| 2025-06-23 | NAZEM FARZAD |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to reporting person's continuous status as a "Service Provider" (as defined in the the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, one-twelfth (1/12th) of the shares subject to the Option shall vest on a monthly basis following the date of grant on the same day of the month as such grant date (or on the last day of the month, if there is no corresponding day in such month). |
Stock Option (Right to Buy)
|
45,000 |
| 2025-05-29 | Mowry Anna |
CFO and Treasurer |
Buy↑
Filing footnotes — Common Stock (Direct)
Represents the weighted average share price of an aggregate total of 15,000 shares purchased in the price range of $0.7662 to $0.7489 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price. Includes the following shares of Common Stock acquired through the Issuer's 2021 Employee Stock Purchase Plan: (i) 1,250 shares on December 1, 2022; (ii) 1,250 shares on June 1, 2023; (iii) 1,250 shares on December 1, 2023; (iv) 2,500 shares on May 31, 2024; (v) 2,500 shares on November 29, 2024; and (vi) 2,500 shares on May 30, 2025. |
Common Stock
|
15,000 |
| 2025-05-12 | Mallick Parag |
Director, Chief Scientist, 10% Owner |
Buy↑
Filing footnotes — Common Stock (Direct)
Represents the weighted average share price of an aggregate total of 1,500 shares purchased in the price range of $0.7229 to $0.7334 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |
Common Stock
|
1,500 |
| 2025-05-08 | Mallick Parag |
Director, Chief Scientist, 10% Owner |
Buy↑
Filing footnotes — Common Stock (Direct)
Represents the weighted average share price of an aggregate total of 12,000 shares purchased in the price range of $0.7058 to $0.7520 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |
Common Stock
|
12,000 |
| 2025-03-20 | Patel Sujal M |
Director, CEO, President, and Secretary, 10% Owner |
Buy↑
Filing footnotes — Common Stock (Direct)
Represents the weighted average share price of an aggregate total of 23,933 shares purchased in the price range of $0.9351 to $1.06 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |
Common Stock
|
23,933 |
| 2025-03-19 | Patel Sujal M |
Director, CEO, President, and Secretary, 10% Owner |
Buy↑
Filing footnotes — Common Stock (Direct)
Represents the weighted average share price of an aggregate total of 53,300 shares purchased in the price range of $0.9469 to $1.10 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |
Common Stock
|
53,300 |
| 2025-03-03 | Murphy Matthew B. |
General Counsel |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the Vesting Commencement Date, as defined below, and the balance of the shares subject to the Option shall vest and become exercisable on a ratable, monthly basis over the 36 months succeeding such first anniversary so long as the Reporting Person remains a Service Provider as provided in the Issuer's 2021 Equity Incentive Plan. Vesting Commencement Date shall mean January 1, 2025. |
Stock Option (Right to Buy)
|
160,000 |
| 2025-03-03 | Mallick Parag |
Director, Chief Scientist, 10% Owner |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the Vesting Commencement Date, as defined below, and the balance of the shares subject to the Option shall vest and become exercisable on a ratable, monthly basis over the 36 months succeeding such first anniversary so long as the Reporting Person remains a Service Provider as provided in the Issuer's 2021 Equity Incentive Plan. Vesting Commencement Date shall mean January 1, 2025. |
Stock Option (Right to Buy)
|
280,000 |
| 2025-03-03 | Mowry Anna |
CFO and Treasurer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the Vesting Commencement Date, as defined below, and the balance of the shares subject to the Option shall vest and become exercisable on a ratable, monthly basis over the 36 months succeeding such first anniversary so long as the Reporting Person remains a Service Provider as provided in the Issuer's 2021 Equity Incentive Plan. Vesting Commencement Date shall mean January 1, 2025. |
Stock Option (Right to Buy)
|
160,000 |
| 2025-03-03 | Sankar Subramanian |
Senior VP, Product Development |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the Vesting Commencement Date, as defined below, and the balance of the shares subject to the Option shall vest and become exercisable on a ratable, monthly basis over the 36 months succeeding such first anniversary so long as the Reporting Person remains a Service Provider as provided in the Issuer's 2021 Equity Incentive Plan. Vesting Commencement Date shall mean January 1, 2025. |
Stock Option (Right to Buy)
|
160,000 |
| 2025-03-03 | Patel Sujal M |
Director, CEO, President, and Secretary, 10% Owner |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the Vesting Commencement Date, as defined below, and the balance of the shares subject to the Option shall vest and become exercisable on a ratable, monthly basis over the 36 months succeeding such first anniversary so long as the Reporting Person remains a Service Provider as provided in the Issuer's 2021 Equity Incentive Plan. Vesting Commencement Date shall mean January 1, 2025. |
Stock Option (Right to Buy)
|
650,000 |
| 2025-03-03 | Nelson Nicholas A. |
CBO & Senior VP, Bus. Dev. |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the Vesting Commencement Date, as defined below, and the balance of the shares subject to the Option shall vest and become exercisable on a ratable, monthly basis over the 36 months succeeding such first anniversary so long as the Reporting Person remains a Service Provider as provided in the Issuer's 2021 Equity Incentive Plan. Vesting Commencement Date shall mean January 1, 2025. |
Stock Option (Right to Buy)
|
160,000 |
| 2025-03-03 | Weld Gwen E |
Chief People Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the Vesting Commencement Date, as defined below, and the balance of the shares subject to the Option shall vest and become exercisable on a ratable, monthly basis over the 36 months succeeding such first anniversary so long as the Reporting Person remains a Service Provider as provided in the Issuer's 2021 Equity Incentive Plan. Vesting Commencement Date shall mean January 1, 2025. |
Stock Option (Right to Buy)
|
160,000 |
| 2025-03-03 | Suzuki Kentaro |
Chief Marketing Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the Vesting Commencement Date, as defined below, and the balance of the shares subject to the Option shall vest and become exercisable on a ratable, monthly basis over the 36 months succeeding such first anniversary so long as the Reporting Person remains a Service Provider as provided in the Issuer's 2021 Equity Incentive Plan. Vesting Commencement Date shall mean January 1, 2025. |
Stock Option (Right to Buy)
|
50,000 |
| 2024-09-23 | Godwin Mary E. |
Senior VP, Operations |
Convert↑
|
Common Stock
|
47,031 |
| 2024-09-23 | Godwin Mary E. |
Senior VP, Operations |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the weighted average share price of an aggregate total of 47,031 shares purchased in the price range of $2.80 to $3.02 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |
Common Stock
|
47,031 |
| 2024-09-23 | Godwin Mary E. |
Senior VP, Operations |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to reporting person's continuous status as a "Service Provider" (as defined in the Nautilus Subsidiary, Inc. 2017 Equity Incentive Plan) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement date is January 21, 2020. |
Stock Option (Right to Buy)
|
47,031 |
| 2024-09-17 | Godwin Mary E. |
Senior VP, Operations |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to reporting person's continuous status as a "Service Provider" (as defined in the Nautilus Subsidiary, Inc. 2017 Equity Incentive Plan) through each vesting date, twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of the Vesting Commencement Date (as defined below), and one thirty-sixth (1/36th) of the remaining shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement date is January 21, 2020. |
Stock Option (Right to Buy)
|
35,000 |
| 2024-09-17 | Godwin Mary E. |
Senior VP, Operations |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the weighted average share price of an aggregate total of 35,000 shares purchased in the price range of $2.80 to $2.99 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |
Common Stock
|
35,000 |
| 2024-09-17 | Godwin Mary E. |
Senior VP, Operations |
Convert↑
|
Common Stock
|
35,000 |
| 2024-09-16 | Suzuki Kentaro |
Chief Marketing Officer |
Other↑
|
No Securities Owned
|
0 |
| 2024-09-16 | Suzuki Kentaro |
Chief Marketing Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the Vesting Commencement Date, and the balance of the shares subject to the Option shall vest and become exercisable on a ratable, monthly basis over the 36 months succeeding such first anniversary so long as the reporting person remains a Service Provider as provided in the Company's 2021 Equity Incentive Plan through each such vesting date. The Vesting Commencement Date is September 16, 2024. |
Stock Option (Right to Buy)
|
375,000 |
| 2024-06-14 | NAZEM FARZAD |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to reporting person's continuous status as a "Service Provider" (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, one-twelfth (1/12th) of the shares subject to the Option shall vest on a monthly basis following the date of grant on the same day of the month as such grant date (or on the last day of the month, if there is no corresponding day in such month). |
Stock Option (Right to Buy)
|
45,000 |
| 2024-06-14 | Pande Vijay Satyanand |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to reporting person's continuous status as a "Service Provider" (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, one-twelfth (1/12th) of the shares subject to the Option shall vest on a monthly basis following the date of grant on the same day of the month as such grant date (or on the last day of the month, if there is no corresponding day in such month). |
Stock Option (Right to Buy)
|
45,000 |
| 2024-06-14 | McIlwain Matthew S |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to reporting person's continuous status as a "Service Provider" (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, one-twelfth (1/12th) of the shares subject to the Option shall vest on a monthly basis following the date of grant on the same day of the month as such grant date (or on the last day of the month, if there is no corresponding day in such month). |
Stock Option (Right to Buy)
|
45,000 |
| 2024-06-14 | Epperly Melissa B, |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to reporting person's continuous status as a "Service Provider" (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, one-twelfth (1/12th) of the shares subject to the Option shall vest on a monthly basis following the date of grant on the same day of the month as such grant date (or on the last day of the month, if there is no corresponding day in such month). |
Stock Option (Right to Buy)
|
45,000 |
| 2024-06-14 | Akinsanya Karen |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to reporting person's continuous status as a "Service Provider" (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, one-twelfth (1/12th) of the shares subject to the Option shall vest on a monthly basis following the date of grant on the same day of the month as such grant date (or on the last day of the month, if there is no corresponding day in such month). |
Stock Option (Right to Buy)
|
45,000 |